Cognex Announces Participation at the Raymond James 47th Annual Institutional Investors Conference
PRNewswire (Wed, 18-Feb 8:00 AM ET)
Cognex Appoints Sami Atiya and Chris Donato to Board of Directors
PRNewswire (Tue, 17-Feb 8:00 AM ET)
Cognex Delivers Consecutive Margin Expansion and 35% Adjusted EPS Growth Amid Strategic Shift
Market Chameleon (Thu, 12-Feb 5:29 AM ET)
Cognex Delivers Sixth Straight Quarter of Margin Expansion and Double-Digit Earnings Growth
Market Chameleon (Thu, 12-Feb 2:06 AM ET)
Cognex Reports Fourth Quarter 2025 Results
PRNewswire (Wed, 11-Feb 4:30 PM ET)
Cognex Announces Participation at Upcoming Investor Conferences
PRNewswire (Tue, 10-Feb 8:01 AM ET)
Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates
PRNewswire (Thu, 15-Jan 8:00 AM ET)
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.
Cognex trades on the NASDAQ stock market under the symbol CGNX.
As of March 26, 2026, CGNX stock price declined to $49.52 with 861,364 million shares trading.
CGNX has a beta of 1.11, meaning it tends to be more sensitive to market movements. CGNX has a correlation of 0.11 to the broad based SPY ETF.
CGNX has a market cap of $8.21 billion. This is considered a Mid Cap stock.
Last quarter Cognex reported $252 million in Revenue and $.27 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.07.
In the last 3 years, CGNX traded as high as $59.88 and as low as $22.67.
The top ETF exchange traded funds that CGNX belongs to (by Net Assets): VTI, IJH, VB, VGT, VBK.
CGNX has outperformed the market in the last year with a price return of +59.5% while the SPY ETF gained +13.7%. CGNX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +35.5% and -2.9%, respectively, while the SPY returned -6.0% and -4.0%, respectively.
CGNX support price is $50.25 and resistance is $52.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGNX shares will trade within this expected range on the day.